InvestorsHub Logo
Followers 17
Posts 4234
Boards Moderated 0
Alias Born 04/13/2016

Re: None

Monday, 05/22/2017 10:03:07 PM

Monday, May 22, 2017 10:03:07 PM

Post# of 275045
Agree to disagree ... and then???

My sense of the numerous posts of late is that very few people have changed their minds as a function of the discussion. I confess to a little 'post fatigue' by seeing largely the same issues rehashed on both sides of the fence. I'm hoping we might all just move on.

Two more issues. First, TRUTH raised the issue of additional funding for Notre Dame, which apparently has a near-term end date. He speculated that KBLB might be switching to a different scientific team. I'm going to suggest a different direction: I believe the recent rounds of genetic modifications, leading to four new strains we have not heard much of, weren't as successful as KBLB hoped. KBLB is therefore paying for an additional round of genetic insertions. The extension is short-term because that is all KBLB can pay for at this point.

Again I call attention to the speculative nature of my claim. I don't have any evidence in support of this idea.

My final issue is something that I didn't see in the latest quarterly report, but may have overlooked. Did they report expenditures to cover travel to Vietnam? I don't recall seeing those charges listed. Also, I've not seen much in the way of operations for their silkworm rearing facility. Do we know how much this is costing them?

Unless I overlooked these expenses, I'm guessing that Kim Thompson paid for these out-of-pocket. That could be a part of the $2m+ he is owed on the books.

If so, it speaks to Mr. Thompson's unwillingness to dilute stock through sales to Calm Seas and also his confidence that KBLB will turn profitable soon.

Any thoughts? I'm not as good at reading financial reports as others on this board.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KBLB News